143 related articles for article (PubMed ID: 22085486)
41. Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.
Bogdanski P; Pupek-Musialik D; Dytfeld J; Jagodzinski PP; Jablecka A; Kujawa A; Musialik K
Int J Clin Pharmacol Ther; 2007 Oct; 45(10):563-7. PubMed ID: 17966842
[TBL] [Abstract][Full Text] [Related]
42. Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.
Chakraborty T; Bose A; Goswami KK; Goswami S; Chakraborty K; Baral R
Int Immunopharmacol; 2012 Feb; 12(2):326-33. PubMed ID: 22210373
[TBL] [Abstract][Full Text] [Related]
43. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
[TBL] [Abstract][Full Text] [Related]
44. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
[TBL] [Abstract][Full Text] [Related]
45. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus.
Zaitseva M; King LR; Manischewitz J; Dougan M; Stevan L; Golding H; Golding B
Infect Immun; 2001 Jun; 69(6):3817-26. PubMed ID: 11349047
[TBL] [Abstract][Full Text] [Related]
46. The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist.
Patel K; Dixit VD; Lee JH; Kim JW; Schaffer EM; Nguyen D; Taub DD
Int J Med Sci; 2012; 9(1):51-8. PubMed ID: 22211090
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
48. Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes.
Mello Coelho Vd; Bunbury A; Rangel LB; Giri B; Weeraratna A; Morin PJ; Bernier M; Taub DD
Int J Med Sci; 2009 Dec; 7(1):1-14. PubMed ID: 20046229
[TBL] [Abstract][Full Text] [Related]
49. CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.
Saika F; Kiguchi N; Kobayashi Y; Fukazawa Y; Kishioka S
Eur J Pain; 2012 Oct; 16(9):1271-80. PubMed ID: 22528550
[TBL] [Abstract][Full Text] [Related]
50. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
[TBL] [Abstract][Full Text] [Related]
51. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
52. Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages.
Ichiyama T; Hasegawa M; Hashimoto K; Matsushige T; Hirano R; Furukawa S
Int Arch Allergy Immunol; 2009; 148(2):147-53. PubMed ID: 18802359
[TBL] [Abstract][Full Text] [Related]
53. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.
Lane BR; Markovitz DM; Woodford NL; Rochford R; Strieter RM; Coffey MJ
J Immunol; 1999 Oct; 163(7):3653-61. PubMed ID: 10490959
[TBL] [Abstract][Full Text] [Related]
54. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
[TBL] [Abstract][Full Text] [Related]
55. Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines.
Madera L; Hancock RE
Biochem Biophys Res Commun; 2015 Aug; 464(3):800-6. PubMed ID: 26168734
[TBL] [Abstract][Full Text] [Related]
56. Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.
Kaur G; Tuen M; Virland D; Cohen S; Mehra NK; Münz C; Abdelwahab S; Garzino-Demo A; Hioe CE
Virology; 2007 Dec; 369(1):214-25. PubMed ID: 17765942
[TBL] [Abstract][Full Text] [Related]
57. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
[TBL] [Abstract][Full Text] [Related]
58. CSF-1 regulates the function of monocytes in Crohn's disease patients in remission.
Nieto JC; Zamora C; Cantó E; Garcia-Planella E; Gordillo J; Ortiz MA; Juárez C; Vidal S
Sci Rep; 2017 Mar; 7(1):92. PubMed ID: 28273887
[TBL] [Abstract][Full Text] [Related]
59. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling.
Bose A; Ghosh D; Pal S; Mukherjee KK; Biswas J; Baral R
Oral Oncol; 2006 Feb; 42(2):161-71. PubMed ID: 16249117
[TBL] [Abstract][Full Text] [Related]
60. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro.
Ubogu EE; Callahan MK; Tucky BH; Ransohoff RM
Cell Immunol; 2006 Sep; 243(1):19-29. PubMed ID: 17257590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
